Evidence map›Paper›PMID 42111057›Full record

ArticlePhysics and imaging in radiation oncology2026

Benchmarking a new radiochromic film type for photon and proton beam dosimetry.

Peter Kuess, Barbara Knäusl, Sarah Helletzgruber, Dietmar Georg, Hugo Palmans, Wolfgang Lechner

Abstract read
In one paragraph

Article in Physics and imaging in radiation oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Peter KuessDepartment of Radiation Oncology, Medical University of Vienna, Währinger Gürtel 18-20, Vienna, A-1090, Austria.
Barbara KnäuslDepartment of Radiation Oncology, Medical University of Vienna, Währinger Gürtel 18-20, Vienna, A-1090, Austria.
Sarah HelletzgruberDepartment of Radiation Oncology, Medical University of Vienna, Währinger Gürtel 18-20, Vienna, A-1090, Austria.
Dietmar GeorgDepartment of Radiation Oncology, Medical University of Vienna, Währinger Gürtel 18-20, Vienna, A-1090, Austria.
Hugo PalmansMedAustron Ion Therapy Center, Marie Curie-Straße 5, Wiener Neustadt, A-2700, Austria.
Wolfgang LechnerDepartment of Radiation Oncology, Medical University of Vienna, Währinger Gürtel 18-20, Vienna, A-1090, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Purpose: EBT4 Radiochromic films (RCFs) are replacing the well-described EBT3 type. This study aimed to benchmark the EBT4 type against its predecessor for photon (kV and MV) and proton beam dosimetry. Materials and Methods: Differences between the film types regarding the signal-to-noise ratio (SNR) were investigated in 6 MV photon and 148.2 MeV proton beams in the dose range of 0.2 Gy to 10 Gy for all RGB channels. The effect of the dose-averaged linear energy transfer (LET Results: The SNR of EBT4 films was statistically superior for MV-photon irradiations above 1.5 Gy in the red channel by up to 29 %. For low-dose proton irradiations, the SNR of EBT3 was higher. The underresponse of both film types in a proton SOBP reached 5 to 7 %. In low kV X-ray beams, EBT4 deviated from EBT3 on average by 2.5 %. For irradiations of films with a dose of 2 Gy or less after 216 days of storage, smaller differences in terms of pixel values were observed for films placed at 10°C. Conclusions: The presented results are in accordance with recent studies on EBT4 films and extend the knowledge on this film type, especially regarding proton beams and film storage.

Indexed as

EBT4 radiochromic filmsFilm dosimetryFilm storageProton dosimetry

Identifiers

PMID42111057
PMCPMC13156622

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.